Short communication · 19 Jun 2021
Conference abstractPublished 7 Sep 2018
Histone Deacetylase Inhibition Restores Expression of Hypoxia-inducible Protein NDRG1 in Pancreatic Cancer
University Hospital Bern, Switzerland
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic ductal adenocarcinoma, the most common subtype of human pancreatic cancer, affects both men and women and is highly aggressive, with a five-year survival rate of only about 5%. N-myc downstream-regulated gene-1 (NDRG1) is a hypoxia-inducible and differentiation-related protein and candidate biomarker in pancreatic cancer. As NDRG1 expression is lost in high-grade tumors, the effects of the differentiating histone deacetylase inhibitor trichostatin A (TSA) were examined in human pancreatic cancer cell lines representing different tumor grades. Panc-1 (poorly differentiated) and Capan-1 (moderately- to well-differentiated) cells were treated with TSA. Effects were assessed in vitro by microscopic analysis, colorimetric assays, cell counts, real-time polymerase chain reaction, and western blotting. Treatment of Panc-1 cells over four days with 0.5 µM TSA restored cellular differentiation, inhibited proliferation, and enhanced p21Cip1 protein expression. TSA upregulated NDRG1 mRNA and protein levels under normoxia from day one and by six-fold by day four (p<0.01 at all time points). After 24 h under hypoxia, NDRG1 expression was further increased in differentiated cells (p<0.01). Favorable changes were identified in the expression of other hypoxia-regulated genes. HDAC inhibitors offer a potential novel epi-drug approach for pancreatic cancer by reversing the undifferentiated phenotype and allowing patients to overcome resistance and better respond to conventional cytotoxic treatments. Restoration of NDRG1 expression may represent a biomarker of malignant pancreatic tumors undergoing re-differentiation and redirecting toward a lower tumor grade. The use of the human ductal Panc-1 cell line treated with TSA represents a useful tool to study cellular differentiation through epigenetic mechanisms.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 19 Sep 2018
Hypoxia-inducible factor-2a facilitates the expression of ZBP-89 and programmed cell death 4 in hepatocellular carcinoma
Conference abstract · 8 Aug 2016
A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells
Conference abstract · 20 Jul 2015
The BET bromodomain inhibitor JQ1 and the histone deacetylase inhibitor panobinostat induce synergistic anticancer effects by repressing LIN28B and N-Myc expression
Conference abstract · 3 Aug 2015
Downregulation of Ca2+-activated Cl- channel TMEM16A by histone deacetylase inhibition in breast cancer cells
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGastroenterology & Hepatology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Céline Tiffon”
